Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...
Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...
The Print on MSN2d
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...
Stocks like Lloyds Metals and Energy, Ashoka Buildcon, CG Power and Industrial Solutions, Unichem Laboratories, Happiest ...
Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...
However, in recent times, pharma stocks have been under pressure, drawing investor attention. Several factors have contributed to this decline. Concerns over potential US tariffs on Indian pharma ...
A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...
Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...
Barclays has been actively involved in private credit transactions, including its recent role in financing Hinduja Group’s ...
The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback